cbdMD, Inc. (YCBD-PA)

USD 0.68

(1.49%)

EBITDA Summary of cbdMD, Inc.

  • cbdMD, Inc.'s latest annual EBITDA in 2023 was -7.46 Million USD , down -80.94% from previous year.
  • cbdMD, Inc.'s latest quarterly EBITDA in 2024 Q3 was 203.55 Thousand USD , up 143.95% from previous quarter.
  • cbdMD, Inc. reported an annual EBITDA of -15.47 Million USD in 2022, up 405.63% from previous year.
  • cbdMD, Inc. reported an annual EBITDA of -22 Million USD in 2021, up 72.24% from previous year.
  • cbdMD, Inc. reported a quarterly EBITDA of -1.55 Million USD for 2024 Q2, down -470.6% from previous quarter.
  • cbdMD, Inc. reported a quarterly EBITDA of 203.55 Thousand USD for 2024 Q3, up 143.95% from previous quarter.

Annual EBITDA Chart of cbdMD, Inc. (2023 - 2016)

Historical Annual EBITDA of cbdMD, Inc. (2023 - 2016)

Year EBITDA EBITDA Growth
2023 -7.46 Million USD -80.94%
2022 -15.47 Million USD 405.63%
2021 -22 Million USD 72.24%
2020 -16.86 Million USD -335.22%
2019 -14.09 Million USD 5621.5%
2018 -1.57 Million USD 155.29%
2017 -789.26 Thousand USD 83.35%
2016 -3.68 Million USD 0.0%

Peer EBITDA Comparison of cbdMD, Inc.

Name EBITDA EBITDA Difference
China Pharma Holdings, Inc. 8436.00 USD 88623.115%
cbdMD, Inc. -7.46 Million USD -0.0%
Zomedica Corp. -29.38 Million USD 74.588%